This study is collecting skin samples from people with congenital heart disease (CHD) to prepare for a future treatment. The goal is to create special cells called induced pluripotent stem cells from your skin, which could then be used in a separate treatment study. By collecting these samples now, the researchers hope to reduce the time it takes to prepare these cells when you might be eligible for that future treatment. You can join if you are 18 or older, have congenital heart disease, and are likely to qualify for a specific future clinical trial (IND 28611). You cannot join if you've had a heart transplant, have HIV or Hepatitis, or are unable to consent. The study will measure if they can successfully make these stem cells within 12 months.

Study design

This is an observational study, meaning it involves collecting information and samples without giving a specific treatment. It plans to enroll about 100 participants.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

The primary goal of successfully manufacturing stem cells is measured at 12 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.